3Salgado CD, Ogragy N, Farr BM. Prevention and control of antimicrobial resistant infections in intensive care patients[J]. Crit Care Med,2005,33(10):2373-2382.
5Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosoeomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study[J].Clin Infect Dis,2004,39(3):309- 317.
6Bouza E, San Juan R, Munoz P,etal. A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study). European Study Group on Nosocomial Infection[J]. Clin Microbio Infect, 2001,7(10) : 532-542.
7HidronAI, Edwards JR, Patel J,et al.Antimicrobial resistant pathogens associated healthcare-associated infections: annual summary of date reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007[J].Infect Control Hosp Epidemiol, 2008, 29 (11) :996-1011.
9Dampis U, Baloe A, Vigante D, et al. Prevalence of nosocomial infection in two Lativan hospitals. http://www.eurosurveillance.org/em/vo8no3/o8o3-223.asp.
10Jarvis WR. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost and prevention. Infect Control and Hosp Epidemiol, 1996, 17: 552-557.
